Navigation Links
Video: New Autoimmunity Public Service Campaign Alerts Men About Their Autoimmune Disease Risk
Date:4/3/2008

Do You Know Your Family AQ?

DETROIT, April 3, 2008 /PRNewswire-USNewswire/ -- What do former President George H.W. Bush, Fox Business News anchor Neil Cavuto, comedian and actor Bernie Mac, Poison lead singer and reality television star Bret Michaels and Seattle Seahawks wide receiver Bobby Engram have in common?

To view the Multimedia News Release, go to:

http://www.prnewswire.com/mnr/aarda/32498/

They are among the millions of American men living with an autoimmune disease today. And, these men are the focus of a new public service campaign launched today by American Autoimmune Related Diseases Association (AARDA).

The "Men Get Autoimmune Diseases, Too" campaign consists of 30-second radio and television public service announcements (PSAs) and educational materials designed to raise awareness about the fact that, while women are disproportionately affected, these diseases do not discriminate when it comes to gender. Specifically, the PSAs inform men about the importance of knowing their family AQ.

"AQ is a play on IQ and stands for Autoimmune Quotient. It's about knowing how likely you are to develop an autoimmune disease given the prevalence of theses disease in your family," explained Virginia Ladd, president and executive director, AARDA.

Men and Autoimmune Disease

While nearly 75 percent of the more than 23.5 million Americans who suffer from autoimmune disease are women, millions of American men suffer from these diseases, too. However, autoimmune diseases that develop in men tend to be more severe.

There are a few autoimmune diseases that men are just as or more likely to develop as women, including:

-- Ankylosing spondylitis

-- Type 1 diabetes

-- Wegener's granulomatosis

-- Psoriasis

In addition, diseases that affect blood vessels can lead to problems with erection. Fo
'/>"/>

SOURCE American Autoimmune Related Diseases (AARDA)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Video: Walgreens to Provide $35 Million in Free Health Screenings with The Take Care Health Tour
2. Video: Could You Be At Risk? American Diabetes Association Sounds the Alert on March 25th - ADAs 20th Annual American Diabetes Alert(R) Day
3. Video: TI unveils industrys first family of complete analog front ends for superior ultrasound systems
4. Video: Clear to Drive Campaign Educates Motorists on How to Prevent Drowsy Driving
5. Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life
6. Video: Colon Cancer Myths Dispelled!
7. Video: DIVABETIC - Makeover Your Diabetes Kicks Off 2008 Events
8. Video: YMCAs Commit to Helping Americans Keep Their New Years Resolutions in Support of Health and Well-Being
9. Video: Studies: Exposure to Ultraviolet Rays Best Way to Overcome Widespread Vitamin D Deficiency
10. Video: New Survey Shows Young Women Turn to Traditional Values in Life, Relationships and Health
11. Video: U.S. Department of Agriculture Partners with Ad Council and Collaborates with Walt Disney Studios Home Entertainment to Promote Nutrition Education to Children and Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...ewswire/ -- The HealthCentral,Network, Inc. (http...pConnection.com, a new online medical and peer-to-...hose struggling with obesity about,drugs, surgerie...scuss and,post questions., Three expert writers, .... Jeffrey Heit, television health reporter Amy Hen...
(Date:7/9/2008)...n that would cut $39 million from,Medicare Advanta...Newswire-USNewswire/ -- Seniors across,Mississippi...icare,Advantage program in legislation being consi...31) would cut $39 million from the Medicare Advant...back the areas where Medicare,private fee-for-serv...
(Date:7/9/2008)...n that would cut $38 million from,Medicare Advanta...ewswire-USNewswire/ -- Seniors across New Mexico,a...are Advantage program in,legislation being conside...) would cut $38 million from the Medicare Advantag...k the areas where Medicare private,fee-for-service...
(Date:7/9/2008)...a larger role in kidney transplants than previousl... well in men due to their smaller size. Women hav...Therefore, in the future, gender should be conside...esearchers from Basel and Heidelberg. , These re...ve Transplant Study", the world,s largest database...
Breaking Medicine News(10 mins):Health News:Responding to Increased Incidence of Obesity and Associated Health Issues, The HealthCentral Network Launches Site to Support those Struggling with Weight 2Health News:Mississippi Seniors Speak Out Against Medicare Advantage Cuts 2Health News:New Mexico Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Male kidneys for men only? 2
...00 people across the UK suffering from liver disea...7,000, according to a report by the Health Protect...who suffer from the chronic hepatitis C infection,...ition. Injected drugs are believed to be responsib...
...for a ban on an artificial sweetener aspartame, wh...dicines, food and drinks.// He said that there was...ed in cereal, chocolate and cola, may cause cancer... reports that aspartame caused cancer in rats. Dos...
...lege and Research Institute (SRMC&RI), and Asia CR...a joint venture towards establishing an exclusive ...mbilical cord blood stem cells are reported to hol... of diseases. The focus of the new center will be ...
...'s disease is expected to rise due to changing lif...osion in developing nations. //As of 2005, 24 mill... to cardiovascular disease, and old age, and by th... to 42 million, and to 81 million by the year 2040...
Other Medicine News:
(Date:7/8/2008)...K, July 8 /- McGraw-Hill Professional...es for the scientific and medical,communities, tod...ectiveness reference to its comprehensive online p...//www.accesspharmacy.com ). Through an alliance wi...ases generated from clinical,studies, AccessPharma...
(Date:7/7/2008)...HCV Development Presence Includes ANA598 and ANA77...Complementary Mechanisms Conferen...- Anadys Pharmaceuticals,I...suming clinical,investigation of the Toll-Like Rec...nic hepatitis C. Based on preclinical pharmacology...
(Date:7/7/2008)...NG, July 7 /- OrbusNeich today announ...l Meeting of the Japanese Society of,Interventiona...eered R,stent has better outcomes when compared to...ione, M.D., the study,s principal,investigator and...ples,s,Division of Cardiology, Department of Clini...
(Date:7/6/2008)...e basis for CTI,s Marketing Authorization Applicat...by the EMEA, SEATTLE, July 7 /PRNewswire-FirstCal... ; MTA) today announced the publication of results...XIO(TM) (paclitaxel poliglumex,CT-2103) with gemc...performance status 2) patients with previously unt...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Providence Holy Cross Medical Center Ignores Community Environmental Concerns With Planned Expansion of Mission Hills Facility 19133 1Providence Holy Cross Medical Center Ignores Community Environmental Concerns With Planned Expansion of Mission Hills Facility 19133 2Cardinal Health Completes Enturia Acquisition 2043 1Cardinal Health Completes Enturia Acquisition 2043 2Federal government taps NC State experts to explain nanotech risks 5330 1Federal government taps NC State experts to explain nanotech risks 5330 2Westaim announces 2008 first quarter results 19126 1Westaim announces 2008 first quarter results 19126 2Westaim announces 2008 first quarter results 19126 3
... 2007 /PRNewswire/ -- Prolexys,Pharmaceuticals and...erties of the selective small molecule anti-tumor ...company,s,chemi-proteomics technology to understan... to be published in the June 14, 2007 issue,of the...hondrial,voltage- dependent anion channels (VDACs)...
...07 /PRNewswire/ -- Two studies presented,today dem... peak,plasma levels, nor did it impair middle-of-t...n patients who suffer from chronic,insomnia. The r...nnual Meeting of the Associated Professional Sleep...ause they show that ROZEREM may be,a safe sleep me...
Other Medicine Technology:Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5
The Reusable Template is designed for use with the Brachystepper® as a guidance system for prostate brachytherapy. Please be sure that the graphics on your software match the graphics on the Reus
The MicroTouch LP (low profile) is specifically designed for use on cystoscopy tables with a fixed fluoroscopy/x-ray gantry. The MicroTouch LP attaches to tables on the side opposite the gantry and a
The Precision Stepper is the first stepper with a fully adjustable baseline. This new technology permits the physician to fine-tune the depth of the ultrasound transducer for accurate imaging and pr
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy.
Medicine Products: